Navigation Links
Stem cells derived from human amniotic fluid hold promise
Date:8/24/2011

F O R I M M E D I A T E R E L E A S E

CELL TRANSPLANTATION The Regenerative Medicine Journal

Stem cells derived from human amniotic fluid hold promise hAECs used to successfully treat animal models of lung disease

Tampa, Fla. (Aug. 24, 2011) Two papers published in the current issue of Cell Transplantation (20:6), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

Amniotic fluid a rich source of mesenchymal stromal cells "Stem cells isolated from human amniotic fluid (AFSs) have the ability to differentiate into different cell types," said study corresponding author Dr. Cesar V. Borlongan, professor and vice chair for research in the University of South Florida's Department of Neurosurgery and Brain Repair. "Recent research has shown that amniotic fluid-derived stem cells show similarities to both embryonic and adult stem cells and can differentiate into many different kinds of cells." The study authors determined that amniotic fluid-derived stem cells represent not only a promising source of stem cells for further research, but may also serve as a "customized cell supply" for the newly born. The cells have the capacity to be "banked" for transplantation in immunologically-matched recipients. According to the authors, AFSs can give rise to adipogenic, osteogenic, myogenic, neurogenic and hepatic cell lineages. The cells, they said, are "intermediate between embryonic stem cells and adult stem cells." "These cells have a high renewal capacity and can be expanded without loss of cellular integrity, such as a loss of chromosomal telomere length," explained Dr. Borlongan. "We need further investigations to fully explore the amniotic cells' potential for treating adult human disorders." Contact: Dr. Cesar V. Borlongan, professor and vice chair for research, Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL 33612 Tel. (813) 974-3154 Fax. (813) 974-3078 Email cborlong@health.usf.edu

Citation: Antonucci, I.; Stuppia, L.; Kaneko, Y.; Yu, S.; Tajiri, N.; Bae, E. C.; Chheda, S. H.; Weinbren, N. L.; Borlongan, C. V. Amniotic Fluid as Rich Source of Mesenchymal Stromal Cells for Transplantation Therapy. Cell Transplant. 20(6):789-795; 2011.

Tampa, Fla. (Aug. 24, 2011) Two papers published in the current issue of Cell Transplantation (20:6), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

Amniotic fluid a rich source of mesenchymal stromal cells

"Stem cells isolated from human amniotic fluid (AFSs) have the ability to differentiate into different cell types," said study corresponding author Dr. Cesar V. Borlongan, professor and vice chair for research in the University of South Florida's Department of Neurosurgery and Brain Repair. "Recent research has shown that amniotic fluid-derived stem cells show similarities to both embryonic and adult stem cells and can differentiate into many different kinds of cells."

The study authors determined that amniotic fluid-derived stem cells represent not only a promising source of stem cells for further research, but may also serve as a "customized cell supply" for the newly born. The cells have the capacity to be "banked" for transplantation in immunologically-matched recipients.

According to the authors, AFSs can give rise to adipogenic, osteogenic, myogenic, neurogenic and hepatic cell lineages. The cells, they said, are "intermediate between embryonic stem cells and adult stem cells."

"These cells have a high renewal capacity and can be expanded without loss of cellular integrity, such as a loss of chromosomal telomere length," explained Dr. Borlongan. "We need further investigations to fully explore the amniotic cells' potential for treating adult human disorders."


'/>"/>

Contact: David Eve
celltransplantation@gmail.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. NSF funds new Center for the Physics of Living Cells at Illinois
3. When cells go bad
4. The role of stem cells in renewing the cornea
5. Breast cancer cells recycle to escape death by hormonal therapy
6. Models of eel cells suggest electrifying possibilities
7. Scientists identify a molecule that coordinates the movement of cells
8. Form of Crohns disease traced to disabled gut cells
9. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
10. Researchers design artificial cells that could power medical implants
11. Stabilizing force for good communication between neurons and muscle cells found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2016)... --> --> ... and Access Management Market by Component (Provisioning, Directory Services, ... Organization Size, by Deployment, by Vertical, and by Region ... market is estimated to grow from USD 7.20 Billion ... a Compound Annual Growth Rate (CAGR) of 12.2% during ...
(Date:3/9/2016)... 2016 Nigeria . ... than 23,000 public service employees either did not exist ... salary unlawfully.    --> Nigeria ... more than 23,000 public service employees either did not ... their salary unlawfully.    --> DERMALOG, the ...
(Date:3/3/2016)... -- FlexTech, a SEMI Strategic Association Partner, awarded five FLEXI ... Leadership in Education, and, in a category new this ... year of the FLEXI Awards and the winners join ... past years . Judging was done on a set ... by a panel of non-affiliated, independent, industry experts. ...
Breaking Biology News(10 mins):
(Date:5/6/2016)... ... May 06, 2016 , ... ... release, Clinical Studio Version 4.1, greatly improves performance of the platform. In particular, ... often generate tremendous volumes of data to be collected on a per patient ...
(Date:5/5/2016)... ON (PRWEB) , ... May 05, 2016 , ... ... following the previously announced identification of its first three targets, it has identified ... misfolded Amyloid beta (Aß), implicated in the development and progression of Alzheimer’s disease ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, 2016 , ... ... neurofibromatosis (NF), a genetic disorder that causes tumors to grow on nerves throughout the ... treatment or cure. , Through numerous community events held during the month of May, ...
(Date:5/3/2016)... San Francisco, CA (PRWEB) , ... May 03, ... ... Morf Playbook™ enterprise talent development, skill-building and compliance training platform on ... Direct training course: Overview of Regulatory Requirements for Medical Devices. The course ...
Breaking Biology Technology: